Now's a good time to do a few deals... 8 Biotec
Post# of 30028
Posted On: 01/20/2015 10:21:34 PM
Now's a good time to do a few deals...
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
by Adam Feuerstein - 01/20/15 - 10:18 AM EST
1. Valuation: Optimism is everywhere. Science is winning, solving problems once thought unsolvable. Disease is being cured. Biotech stock prices march inexorably higher. The industry is awash in cash. Deals and initial public offerings set records. The biotech party rages and no one's ready to go home.
We may be experiencing a "new dawn for biotech," but will the sun set and when? To participate in the biotech thrill-a-thon, investors are paying ever-rising prices for relatively unproven, earlier stage assets. Agios Pharma (AGIO) . Bluebird Bio (BLUE - Get Report) . Kite Pharma (KITE) . Juno Therapeutics (JUNO) . These are all exciting and innovative companies all, but their stock prices and valuations are pricing in greatness and then some. "Risk" is no longer a four-letter word, it appears to be forgotten altogether. Science is improving, but what happens if (when) something goes wrong?
http://www.thestreet.com/story/13015909/1/8-b..._ven=YAHOO
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
by Adam Feuerstein - 01/20/15 - 10:18 AM EST
1. Valuation: Optimism is everywhere. Science is winning, solving problems once thought unsolvable. Disease is being cured. Biotech stock prices march inexorably higher. The industry is awash in cash. Deals and initial public offerings set records. The biotech party rages and no one's ready to go home.
We may be experiencing a "new dawn for biotech," but will the sun set and when? To participate in the biotech thrill-a-thon, investors are paying ever-rising prices for relatively unproven, earlier stage assets. Agios Pharma (AGIO) . Bluebird Bio (BLUE - Get Report) . Kite Pharma (KITE) . Juno Therapeutics (JUNO) . These are all exciting and innovative companies all, but their stock prices and valuations are pricing in greatness and then some. "Risk" is no longer a four-letter word, it appears to be forgotten altogether. Science is improving, but what happens if (when) something goes wrong?
http://www.thestreet.com/story/13015909/1/8-b..._ven=YAHOO
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼